P-L10 Individualized Enhanced recovery after surgery improves postoperative outcomes in hepatocellular carcinoma patients

Abstract Background Hepatocellular carcinoma (HCC) patients often undergo curative liver resection to treat this form of cancer. Hepatectomy is, however, a major surgery associated with many significant risks including prolonged hospitalization, high costs, impaired physiological function, and postoperative complication rates. Enhanced recovery after (ERAS) is multidisciplinary approach that seeks expedite in undergoing surgeries order lower This study was thus designed assess the efficacy safety individualized ERAS approaches hepatectomy. Methods In total, we retrospectively analyzed data from 90 HCC underwent hepatectomy between October 2018 August 2019. All met enrollment criteria provided written informed consent participate. studies were approved by Hospital Research Ethics Committee consistent Declaration Helsinki. Patients randomly divided into two groups (n = 45 each) based on employed perioperative treatment strategies: conventional group an group. Key outcomes then compared groups, pain scores, duration medical rates readmission. Results scores at 24, 48, 72 h post-treatment (P < 0.05), shorter hospitalization (8.16 days vs.10.49 days; P 0.004), costs 0.004) as traditional treatment. No differences > 0.05) or readmission 0.557) observed these groups. Conclusions Individualized improves patient more effectively than